PROTOCIN^®

( Tribulus terestris L. plant extract)

• Administration of PROTINCIN^® increased the numbers of spermatogonia, spermatocytes, spermatids and mature spermatozoa in the testes.
• The percentage of motile spermatozoa increases, the characteristics of their motility improve, prolonging the period of their viability at the same time.

• It stimulates the release of luteinizing hormone (LH) from the pituitary gland which in turn stimulates testosterone production.
• Restores and enhances libido, erection, ejaculation, and orgasm of sexual intercourse.
• It also increases dehydroepiandrosterone (DHEA) production by the adrenal glands. This steroid precursor becomes testosterone.
• Another activity that is connected to Protodiocin is the release of nitric oxide from the nerve endings in the penis.
• Tribulus terrestris is thus also known to help with attaining erection.

1. Viktorov, E. Bozadjieva, M. Protich, etal. High Medical Institute; Medical Academy Institute of Endocrinology, Gerontology and Geriatrics; Medical Academy Institute of Obstetrics and Gynecology, Bulgaria IIMS Therapeutic Focus (1994)
2. Gaby AR (1993). DHEA: The hormone that “does it all”. Holistic Medicine. pp. 19-24. Hafez ESE and Prasad MRN (1976). Functional aspects of the epididymis. In Human Semen and Fertility Regulation in Men. Pp. 31-43. ESE
   Hafez editor. The CV Mosby Company, St. Louis.
3. Moeloek N, Adimoelja A, Tanojo T, Pangkahila W (1994). Trials of Tribulus terrestris on oligozoospermia. Proceedings of the Vith National Congress and IIIrd International Symposium on New Perpectives on Andrology in Human Reproduction. National Congress of Indonesian Association of Andrology (PANDI) in Mando, Indonesia.
4. Adimoelja A., (1996) Sex Therapy in Asian Conference of Sexology in Taipei, Taiwan.
5. Adimoelja A., Suryaatmadja S., Setiawan L., and Tanojo T. (1997) Protodioscin, the main active component in Tribulus terrestris L. may improve sperm function in subfertile males and increase the frequency of successful intercourse in men with erectile dysfunctions. VII National Congress of Andrology in Bandung, Indonesia.
6. Dyner T.S. etal. (1993) An open label dose escaltion trial of oral DHEA tolerance and Pharmacokinetics in patients
   with HIV-disease. J. AIDS 6(5): 459-465.

Products under patent shall not be offered to the market where the intellectual property rights are protected

Disclaimer : These claims have not been evaluated by the Food and Drug Administration. These products are not intended to cure, mitigate, treat or prevent any disease